Core Insights - OraSure Technologies, Inc. has received FDA approval for a labeling change to the OraQuick® HIV Self-Test, expanding its use to adolescents aged 14 and older, previously limited to those 17 and older [1] - The change aims to increase access to HIV testing for young people, addressing a significant gap as 19% of new HIV diagnoses in the U.S. are among individuals aged 13 to 24, with only 6% of high school students having ever been tested [2][3] Company Overview - OraSure Technologies is a leader in point-of-need and home diagnostic tests, focusing on improving access to healthcare through innovative testing solutions [1][4] - The company has been committed to providing consumers with critical information and connections to care since the launch of the OraQuick® HIV Self-Test in 2012, which includes educational materials and care linkage information [3][4] Industry Context - Increasing access to HIV testing options is crucial for ending the HIV epidemic, particularly for adolescents who test positive, emphasizing the need for early connection to care [3] - The approval of the OraQuick® HIV Self-Test for younger populations is a strategic move to combat the stigma surrounding HIV testing and improve awareness among adolescents [3]

Company Overview - OraSure Technologies, Inc. is focused on transforming health through actionable insights and improving access, quality, and value of healthcare with innovative testing solutions [4] - The company, along with its subsidiaries, is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection devices [4] Product Update - The OraQuick HIV Self-Test has expanded its approved age range to include individuals aged 14 and older, previously limited to those 17 and older [1] - This change aims to increase access to HIV testing for adolescents, addressing a significant gap in testing among young people [1][3] Market Context - According to the CDC, 19% of new HIV diagnoses in the U.S. are among individuals aged 13 to 24, with only 6% of high school students having ever been tested for HIV [2] - Nearly half of young people with HIV are unaware of their status, highlighting the need for increased testing options [2] Company Commitment - OraSure is dedicated to promoting HIV testing and reducing the stigma associated with infection, providing educational materials and care linkage information with its products [3] - The OraQuick HIV Self-Test has been available to consumers in the U.S. since 2012, reflecting the company's long-term commitment to improving access to critical health information [3]

OraSure Technologies, Inc. (OSUR) recently announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers.This acquisition enhances OraSure’s innovation pipeline by incorporating Sherlock Biosciences’ molecular diagnostics platform. This platform delivers rapid results with high sensitivity and specificity in a disposable format ideal for over-the-counter use.Likely Trend of OSUR Stock Following the NewsFollowing th ...

BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OTI") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers. This acquisition expands OraSure's innovation pipeline with the addition of Sherlock's molecular diagnostics platform, which is able to provide rapid results with s ...

I worked for many years at an investment firm where I invested across public and private market opportunities. I underwrote fund managers, as well as individual securities. I left the firm to pursue an MBA from a Top-20 US B School. At school, I won the nation's premier stock pitching competition and was portfolio manager for the school's Consumer sector investments. During that time, I interned at a multi-family office and a hedge fund. I became adept at using Bloomberg and Factset for research. On top of ...

BETHLEHEM, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions, today announced that it received an award through the Rapid Response Partnership Vehicle (RRPV) for the development of a Marburg Virus Disease (MVD) rapid antigen test. The RRPV is a Consortium funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Resp ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use tried-and-true metrics an ...

BETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment Conference on Wednesday, November 20, with a Q&A session scheduled for 1 p.m. ET A live webcast and replay of the Q&A session will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. The webcast will be archived on OraSure’s ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value ...

OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President & Chief Executive Officer Kenneth McGrath - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Casey Woodring - JPMorgan Operator Good day, and thank you for standing by. Welcome to the OraSure Technologies Inc. 2024 Third Quarter Earnings Conference Call. At this time, all participa ...